THE CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS awarded 35 new grants totaling around $79.2 million. Thirty-three of the grants were made through CPRIT’s academic research program and two through its product development research program. The academic research grants, totaling approximately $45.3 million, include around $19.7 million for funding of four Core Facility Support Awards....
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
